Background: Studies suggest end-stage renal disease incidence and all-cause mortality rates among patients with chronic kidney disease (CKD) differ by age. The association of diabetes mellitus and ...

Body-weight cycling (also known as yo-yo dieting) has been shown to significantly increase the risk of kidney disease in people with type 1 diabetes, regardless of body mass index (BMI) and other ...

Share on Pinterest The FDA approved Ozempic to help lower chronic kidney disease-related risks in people with type 2 diabetes. urbazon/Getty Images The Food and Drug Administration (FDA ...

The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes ...

Research shows that body-weight cycling significantly increases the risk of kidney disease in individuals with Type 1 ...